GeoVax (United States)

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Paul A. Goepfert, Marnie Elizaga, Alicia Sato et al. · The Journal of Infectious Diseases · 2011 · 176 citations · Full text

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model

Aaron C. Brault, Arban Domi, Erin McDonald et al. · Scientific Reports · 2017 · 121 citations · Full text

Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

Lilin Lai, Suefen Kwa, Pamela A. Kozlowski et al. · The Journal of Infectious Diseases · 2011 · 98 citations · Full text

Vaccinology, Vaccination, Mucosal Vaccination +13

DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

Vainav Patel, Rashmi Jalah, Viraj Kulkarni et al. · Proceedings of the National Academy of Sciences · 2013 · 76 citations · Full text

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses

Lilin Lai, Sue-Fen Kwa, Pamela A. Kozlowski et al. · Vaccine · 2011 · 60 citations · Full text

Vaccination, Vaccine Development, Immunology +5